133 related articles for article (PubMed ID: 23141166)
1. Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
Begum-Haque S; Christy M; Wang Y; Kasper E; Ochoa-Reparaz J; Smith JY; Haque A; Kasper LH
J Neuroimmunol; 2013 Jan; 254(1-2):117-24. PubMed ID: 23141166
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Kasper IR; Foureau DM; Mielcarz DW; Haque A; Kasper LH
J Neuroimmunol; 2008 Nov; 204(1-2):58-65. PubMed ID: 18804287
[TBL] [Abstract][Full Text] [Related]
4. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
5. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.
Murugaiyan G; Mittal A; Weiner HL
J Immunol; 2008 Dec; 181(11):7480-8. PubMed ID: 19017937
[TBL] [Abstract][Full Text] [Related]
6. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
7. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
8. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
9. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.
Vieira PL; Heystek HC; Wormmeester J; Wierenga EA; Kapsenberg ML
J Immunol; 2003 May; 170(9):4483-8. PubMed ID: 12707324
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer acetate (Copaxone) regulates nitric oxide and related cytokine secretion in experimental autoimmune encephalomyelitis.
Kayhan B; Aharoni R; Arnon R
Immunol Lett; 2003 Sep; 88(3):185-92. PubMed ID: 12941477
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.
Begum-Haque S; Christy M; Ochoa-Reparaz J; Nowak EC; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2011 Mar; 232(1-2):136-44. PubMed ID: 21111489
[TBL] [Abstract][Full Text] [Related]
12. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
[TBL] [Abstract][Full Text] [Related]
13. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
[TBL] [Abstract][Full Text] [Related]
14. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
[TBL] [Abstract][Full Text] [Related]
15. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
16. The effect of 1, 25(OH)2 D3 (calcitriol) alone and in combination with all-trans retinoic acid on ROR-γt, IL-17, TGF-β, and FOXP3 gene expression in experimental autoimmune encephalomyelitis.
Parastouei K; Mirshafiey A; Eshraghian MR; Shiri-Shahsavar MR; Solaymani-Mohammadi F; Chahardoli R; Alvandi E; Saboor-Yaraghi AA
Nutr Neurosci; 2018 Apr; 21(3):210-218. PubMed ID: 27996890
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis.
Song JY; Griffin JD; Larson NR; Christopher MA; Middaugh CR; Berkland CJ
Front Immunol; 2020; 11():603029. PubMed ID: 33537031
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid ameliorates experimental allergic encephalomyelitis by affecting dendritic cell and monocyte development.
Zhan XX; Liu Y; Yang JF; Wang GY; Mu L; Zhang TS; Xie XL; Wang JH; Liu YM; Kong QF; Li HL; Sun B
Immunology; 2013 Apr; 138(4):333-45. PubMed ID: 23181351
[TBL] [Abstract][Full Text] [Related]
20. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
Aharoni R; Eilam R; Stock A; Vainshtein A; Shezen E; Gal H; Friedman N; Arnon R
J Neuroimmunol; 2010 Aug; 225(1-2):100-11. PubMed ID: 20554028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
